Instil Bio (TIL) Market Capitalization (2021 - 2026)

Instil Bio has reported Market Capitalization for 6 years, with the latest figure at $52.2 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 62.91% year-over-year to $52.2 million in Q2 2026; TTM through Jun 2026 was $52.2 million, a 62.91% decrease from a year earlier, with the FY2025 full-year figure at $74.6 million, down 40.12% from the prior year.
• Market Capitalization was $52.2 million for Q2 2026 at Instil Bio, down from $55.9 million in the prior quarter.
• The five-year high for Market Capitalization was $1.4 billion in Q1 2022, with the low at $49.6 million in Q4 2023.
• Average Market Capitalization over 5 years is $234.4 million, with a median of $84.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization tumbled 95.48% in 2022, then soared 689.03% in 2024.
• Over 5 years, Market Capitalization stood at $81.9 million in 2022, then sank by 39.52% to $49.6 million in 2023, then soared by 151.37% to $124.6 million in 2024, then slumped by 40.12% to $74.6 million in 2025, then plunged by 30.09% to $52.2 million in 2026.
• The last three Market Capitalization figures came in at $52.2 million (Q2 2026), $55.9 million (Q1 2026), and $74.6 million (Q4 2025), per Business Quant data.